17.68

2.16% -0.39

After Hours: 17.61 -0.07 -0.40%

Mediwound Ltd (MDWD)

Overview News Price History Option Chain Discussions Forecast Stock Split

Mediwound Ltd stock is traded at $17.68, with a volume of 33,168. It is down -2.16% in the last 24 hours and down -2.59% over the past month. MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Previous Close:

$18.07

Open:

$17.98

24h Volume:

33,168

Relative Volume:

0.36

Market Cap:

$226.68M

Revenue:

$19.85M

Net Income/Loss:

$-12.75M

P/E Ratio:

-12.81

EPS:

-1.38

Net Cash Flow:

$-21.94M

1W Performance:

-1.34%

1M Performance:

-2.59%

6M Performance:

-18.41%

1Y Performance:

-2.16%

1-Day Range:

$17.61

$18.00

1-Week Range:

$17.10

$18.18

52-Week Range:

$14.14

$22.50

Mediwound Ltd Stock (MDWD) Company Profile

Name

Mediwound Ltd

Sector

Healthcare (1133)

Industry

Biotechnology (634)

Phone

Address

Employee

111

Twitter

Next Earnings Date

2025-03-19

Latest SEC Filings

MDWD's Discussions on Twitter

Compare MDWD with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MDWD Mediwound Ltd	17.68	230.53M	19.85M	-12.75M	-21.94M	-1.38
VRTX Vertex Pharmaceuticals Inc	455.48	116.04B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	718.36	75.97B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	458.12	61.48B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	901.17	56.40B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	204.00	43.73B	447.02M	-1.18B	-906.14M	-6.1812

Mediwound Ltd Stock (MDWD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-02-25	Resumed	Oppenheimer	Outperform
May-02-25	Initiated	Alliance Global Partners	Buy
Feb-28-25	Initiated	Craig Hallum	Buy
Jul-16-24	Reiterated	Maxim Group	Buy
Dec-22-22	Initiated	Maxim Group	Buy
Jul-18-22	Resumed	Oppenheimer	Outperform
Sep-23-20	Initiated	BTIG Research	Buy
Nov-28-16	Initiated	Aegis Capital	Buy
Aug-17-16	Initiated	Wells Fargo	Outperform
Apr-16-14	Initiated	Oppenheimer	Outperform

View All

Mediwound Ltd Stock (MDWD) Latest News

03:25 AM

How analysts rate MediWound Ltd. stock todayWeekly Market Outlook & Precise Swing Trade Alerts - Newser

03:25 AM

Dec 02, 2025

What technical charts say about MediWound Ltd. stockJuly 2025 Fed Impact & Consistent Profit Alerts - Newser

Dec 02, 2025

Nov 30, 2025

MediWound Ltd. (NASDAQ:MDWD) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 30, 2025

Nov 29, 2025

Understanding Momentum Shifts in (MDWD) - news.stocktradersdaily.com

Nov 29, 2025

Nov 27, 2025

Will MediWound Ltd. stock deliver long term returnsMarket Trend Report & Long-Term Safe Return Strategies - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025

MediWound Is Showing How a GLP-1-Style Shift Could Happen in Wound Care (NASDAQ: MDWD) - TradingView

Nov 26, 2025

Nov 23, 2025

The MediWound Ltd. (NASDAQ:MDWD) Third-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st

Nov 23, 2025

MediWound’s Q3 2025: Growth and Strategic Advances - MSN

Nov 23, 2025

Nov 22, 2025

MediWound (NASDAQ:MDWD) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Nov 22, 2025

MediWound (NASDAQ:MDWD) Upgraded at Wall Street Zen - Defense World

Nov 22, 2025

Q3 2025 Mediwound Ltd Earnings Call Transcript - GuruFocus

Nov 22, 2025

Nov 21, 2025

MediWound stock price target raised to $36 from $31 at H.C. Wainwright - Investing.com Australia

Nov 21, 2025

Mediwound earnings beat by $0.57, revenue fell short of estimates - Investing.com South Africa

Nov 21, 2025

HC Wainwright & Co. Maintains MediWound (MDWD) Buy Recommendation - MSN

Nov 21, 2025

MediWound (MDWD) Reports Q3 Loss, Misses Revenue Estimates - sharewise.com

Nov 21, 2025

Nov 20, 2025